Yolanda Montes-Gonzalez
Girona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Optical Genome Mapping (OGM): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma.
Journal: American journal of hematology
Published: March 24, 2025
Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease.
Journal: Annals of hematology
Published: July 24, 2024
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection.
Journal: Haematologica
Published: August 25, 2023
Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study.
Journal: Leukemia & lymphoma
Published: August 04, 2023
CD200 genotype is associated with clinical outcome of patients with multiple myeloma.
Journal: Frontiers in immunology
Published: July 03, 2023
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma.
Journal: Frontiers in immunology
Published: February 03, 2023
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 02, 2022
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 14, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026